{"id":2637,"date":"2020-09-29T13:07:12","date_gmt":"2020-09-29T13:07:12","guid":{"rendered":"http:\/\/drupal.test\/projects\/identification-des-biomarqueurs-qui-prevoient-la-gravite-des-patients-de-la-covid-19\/"},"modified":"2022-07-26T12:13:26","modified_gmt":"2022-07-26T16:13:26","slug":"identification-des-biomarqueurs-qui-prevoient-la-gravite-des-patients-de-la-covid-19","status":"publish","type":"project","link":"https:\/\/genomecanada.ca\/fr\/project\/identification-des-biomarqueurs-qui-prevoient-la-gravite-des-patients-de-la-covid-19\/","title":{"rendered":"Identification des biomarqueurs qui pr\u00e9voient la gravit\u00e9 des patients de la COVID-19"},"content":{"rendered":"<p>Un d\u00e9fi important de cette pand\u00e9mie de SRAS-CoV-2 (COVID-19) est d\u2019affecter comme il se doit les ressources m\u00e9dicales limit\u00e9es au tr\u00e8s grand nombre de patients pr\u00e9sentant des sympt\u00f4mes. M\u00eame apr\u00e8s un r\u00e9sultat positif \u00e0 un test du virus de la COVID-19, il est difficile de pr\u00e9voir rapidement et pr\u00e9cis\u00e9ment si un patient souffrira d\u2019un cas grave de la maladie et n\u00e9cessitera une hospitalisation, ou d\u2019un cas l\u00e9ger, dans lequel cas il pourra \u00eatre soign\u00e9 \u00e0 la maison sans danger. Il est particuli\u00e8rement difficile de pr\u00e9voir cette information chez les patients \u00e2g\u00e9s de plus de 60\u00a0ans, ou chez ceux souffrant d\u2019affections sous-jacentes. Nos \u00e9tudes ant\u00e9rieures sur l\u2019\u00e9pid\u00e9mie de SRAS-CoV en\u00a02002-2003, et sur la pand\u00e9mie d\u2019influenza en\u00a02009, a d\u00e9montr\u00e9 que les biomarqueurs et l\u2019expression g\u00e9n\u00e9tique des leucocytes pouvaient \u00eatre utilis\u00e9s pour faire la distinction entre les cas l\u00e9gers et graves de SRAS au niveau mol\u00e9culaire. Cette initiative en cours sera caract\u00e9ris\u00e9e par des \u00e9tudes r\u00e9trospectives et prospectives des biomarqueurs chez des patients de la COVID-19 au Canada, en Chine, aux \u00c9tats-Unis et en Espagne, ainsi que dans des pays \u00e0 revenu faible ou interm\u00e9diaire, au moyen d\u2019une plateforme de 60\u00a0biomarqueurs avec s\u00e9quen\u00e7age de l\u2019ARN et s\u00e9quen\u00e7age de cellule unique de patients de la COVID-19. Identifier et quantifier de tels biomarqueurs en rapport avec la progression et la gravit\u00e9 de la maladie de COVID-19 nous permettra d\u2019\u00e9laborer, ou de contribuer \u00e0 \u00e9laborer, des outils et des protocoles d\u2019\u00e9valuation des patients rapides et fiables, ainsi que des appareils au point de service, qui miseront sur les biomarqueurs relev\u00e9s pendant ce travail. En outre, la nature prospective de cette \u00e9tude ainsi que le s\u00e9quen\u00e7age de l\u2019ARN et le s\u00e9quen\u00e7age de cellule unique permettront d\u2019obtenir une image claire de l\u2019immunit\u00e9 de l\u2019h\u00f4te pendant l\u2019\u00e9volution de la maladie de COVID-19 chez les patients ayant des cas l\u00e9gers, graves et critiques. Enfin, cette recherche rel\u00e8vera des corr\u00e9lats de protection dans des essais de vaccins potentiels au SRAS-CoV-2. Ces concepts seront mis en \u0153uvre en partenariat avec l\u2019autorit\u00e9 sanitaire de la Nouvelle-\u00c9cosse et d\u2019autres provinces ou territoires \u00e0 l\u2019\u00e9chelle du Canada, ainsi qu\u2019\u00e0 travers le monde comme d\u00e9crit dans la section suivante.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Un d\u00e9fi important de cette pand\u00e9mie de SRAS-CoV-2 (COVID-19) est d\u2019affecter comme il se doit les ressources m\u00e9dicales limit\u00e9es au tr\u00e8s grand nombre de patients pr\u00e9sentant des sympt\u00f4mes. M\u00eame apr\u00e8s un r\u00e9sultat positif \u00e0 un test du virus de la COVID-19, il est difficile de pr\u00e9voir rapidement et pr\u00e9cis\u00e9ment si un patient souffrira d\u2019un cas [&hellip;]<\/p>\n","protected":false},"featured_media":0,"template":"","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"project-categories":[],"genome-competitions":[219],"project-sector":[],"genome_centres":[109],"class_list":["post-2637","project","type-project","status-publish","hentry","genome-competitions-initiative-regionale-genomique-sur-la-covid-19","genome_centres-genome-atlantic-fr"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Identification des biomarqueurs qui pr\u00e9voient la gravit\u00e9 des patients de la COVID-19 - GenomeCanada<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/genomecanada.ca\/fr\/project\/identification-des-biomarqueurs-qui-prevoient-la-gravite-des-patients-de-la-covid-19\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Identification des biomarqueurs qui pr\u00e9voient la gravit\u00e9 des patients de la COVID-19 - GenomeCanada\" \/>\n<meta property=\"og:description\" content=\"Un d\u00e9fi important de cette pand\u00e9mie de SRAS-CoV-2 (COVID-19) est d\u2019affecter comme il se doit les ressources m\u00e9dicales limit\u00e9es au tr\u00e8s grand nombre de patients pr\u00e9sentant des sympt\u00f4mes. M\u00eame apr\u00e8s un r\u00e9sultat positif \u00e0 un test du virus de la COVID-19, il est difficile de pr\u00e9voir rapidement et pr\u00e9cis\u00e9ment si un patient souffrira d\u2019un cas [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/genomecanada.ca\/fr\/project\/identification-des-biomarqueurs-qui-prevoient-la-gravite-des-patients-de-la-covid-19\/\" \/>\n<meta property=\"og:site_name\" content=\"GenomeCanada\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-26T16:13:26+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/project\\\/identification-des-biomarqueurs-qui-prevoient-la-gravite-des-patients-de-la-covid-19\\\/\",\"url\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/project\\\/identification-des-biomarqueurs-qui-prevoient-la-gravite-des-patients-de-la-covid-19\\\/\",\"name\":\"Identification des biomarqueurs qui pr\u00e9voient la gravit\u00e9 des patients de la COVID-19 - GenomeCanada\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#website\"},\"datePublished\":\"2020-09-29T13:07:12+00:00\",\"dateModified\":\"2022-07-26T16:13:26+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/project\\\/identification-des-biomarqueurs-qui-prevoient-la-gravite-des-patients-de-la-covid-19\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/project\\\/identification-des-biomarqueurs-qui-prevoient-la-gravite-des-patients-de-la-covid-19\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/project\\\/identification-des-biomarqueurs-qui-prevoient-la-gravite-des-patients-de-la-covid-19\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Identification des biomarqueurs qui pr\u00e9voient la gravit\u00e9 des patients de la COVID-19\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/\",\"name\":\"GenomeCanada\",\"description\":\"Harnessing the transformative power of genomics\",\"publisher\":{\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#organization\",\"name\":\"GenomeCanada\",\"url\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/genomecanada.ca\\\/wp-content\\\/uploads\\\/2021\\\/07\\\/genome-canada_stacked.svg\",\"contentUrl\":\"https:\\\/\\\/genomecanada.ca\\\/wp-content\\\/uploads\\\/2021\\\/07\\\/genome-canada_stacked.svg\",\"width\":285,\"height\":180,\"caption\":\"GenomeCanada\"},\"image\":{\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Identification des biomarqueurs qui pr\u00e9voient la gravit\u00e9 des patients de la COVID-19 - GenomeCanada","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/genomecanada.ca\/fr\/project\/identification-des-biomarqueurs-qui-prevoient-la-gravite-des-patients-de-la-covid-19\/","og_locale":"fr_FR","og_type":"article","og_title":"Identification des biomarqueurs qui pr\u00e9voient la gravit\u00e9 des patients de la COVID-19 - GenomeCanada","og_description":"Un d\u00e9fi important de cette pand\u00e9mie de SRAS-CoV-2 (COVID-19) est d\u2019affecter comme il se doit les ressources m\u00e9dicales limit\u00e9es au tr\u00e8s grand nombre de patients pr\u00e9sentant des sympt\u00f4mes. M\u00eame apr\u00e8s un r\u00e9sultat positif \u00e0 un test du virus de la COVID-19, il est difficile de pr\u00e9voir rapidement et pr\u00e9cis\u00e9ment si un patient souffrira d\u2019un cas [&hellip;]","og_url":"https:\/\/genomecanada.ca\/fr\/project\/identification-des-biomarqueurs-qui-prevoient-la-gravite-des-patients-de-la-covid-19\/","og_site_name":"GenomeCanada","article_modified_time":"2022-07-26T16:13:26+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/genomecanada.ca\/fr\/project\/identification-des-biomarqueurs-qui-prevoient-la-gravite-des-patients-de-la-covid-19\/","url":"https:\/\/genomecanada.ca\/fr\/project\/identification-des-biomarqueurs-qui-prevoient-la-gravite-des-patients-de-la-covid-19\/","name":"Identification des biomarqueurs qui pr\u00e9voient la gravit\u00e9 des patients de la COVID-19 - GenomeCanada","isPartOf":{"@id":"https:\/\/genomecanada.ca\/fr\/#website"},"datePublished":"2020-09-29T13:07:12+00:00","dateModified":"2022-07-26T16:13:26+00:00","breadcrumb":{"@id":"https:\/\/genomecanada.ca\/fr\/project\/identification-des-biomarqueurs-qui-prevoient-la-gravite-des-patients-de-la-covid-19\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/genomecanada.ca\/fr\/project\/identification-des-biomarqueurs-qui-prevoient-la-gravite-des-patients-de-la-covid-19\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/genomecanada.ca\/fr\/project\/identification-des-biomarqueurs-qui-prevoient-la-gravite-des-patients-de-la-covid-19\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/genomecanada.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Identification des biomarqueurs qui pr\u00e9voient la gravit\u00e9 des patients de la COVID-19"}]},{"@type":"WebSite","@id":"https:\/\/genomecanada.ca\/fr\/#website","url":"https:\/\/genomecanada.ca\/fr\/","name":"GenomeCanada","description":"Harnessing the transformative power of genomics","publisher":{"@id":"https:\/\/genomecanada.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/genomecanada.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/genomecanada.ca\/fr\/#organization","name":"GenomeCanada","url":"https:\/\/genomecanada.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/genomecanada.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/genomecanada.ca\/wp-content\/uploads\/2021\/07\/genome-canada_stacked.svg","contentUrl":"https:\/\/genomecanada.ca\/wp-content\/uploads\/2021\/07\/genome-canada_stacked.svg","width":285,"height":180,"caption":"GenomeCanada"},"image":{"@id":"https:\/\/genomecanada.ca\/fr\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/project\/2637","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/project"}],"about":[{"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/types\/project"}],"version-history":[{"count":0,"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/project\/2637\/revisions"}],"wp:attachment":[{"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/media?parent=2637"}],"wp:term":[{"taxonomy":"project-categories","embeddable":true,"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/project-categories?post=2637"},{"taxonomy":"genome-competitions","embeddable":true,"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/genome-competitions?post=2637"},{"taxonomy":"project-sector","embeddable":true,"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/project-sector?post=2637"},{"taxonomy":"genome_centres","embeddable":true,"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/genome_centres?post=2637"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}